Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas

European Journal of Radiology

Volumn 69, Issue 2, 2009, Pages 314-323

  Hennings, Joakim ^a   Hellman, Per ^a   Ahlström, Håkan ^a   Sundin, Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adrenal; CT; Incidentaloma; Metomidate; MRI; PET

Indexed keywords

ADRENAL; CT; INCIDENTALOMA; METOMIDATE; MRI; PET;

ATOMS; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; DIAGNOSTIC RADIOGRAPHY; ELECTRIC INSTRUMENT TRANSFORMERS; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; POSITRON ANNIHILATION SPECTROSCOPY; POSITRONS; RESONANCE; TOMOGRAPHY; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

GERMANIUM 68; ISOTOPE; METOMIDATE C 11; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADRENAL INCIDENTALOMA; ADRENAL METASTASIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; FEMALE; FIBROSIS; FOLLOW UP; HEMATOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; ETOMIDATE; FEMALE; HUMANS; INCIDENTAL FINDINGS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 59649088902     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.10.024     Document Type: Article

References (24)

1. Kloos R., Gross M.D., Francis I., Korobkin M., and Shapiro B. Incidentally discovered adrenal masses. Endocr Rev 16 (1995) 460-484
2. Bulow B., et al. Adrenal incidentaloma-experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 252 (2002) 239-246
3. Bulow B., Jansson S., Juhlin C., et al. Adrenal incidentaloma-follow-up results from a Swedish prospective study. Eur J Endocrinol 154 (2006) 419-423
4. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consens State Sci Statements 2002;19(2):1-25.
5. Del Pizzo J.J. Radiographic evaluation of the incidental adrenal lesion. Curr Urol Rep 7 (2006) 69-72
6. Szolar D., and Kammerhuber F. Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas. Radiology 202 (1997) 517-521
7. Boland G.W., Lee M.J., Gazelle G.S., Halpern E.F., McNcholas M.M., and Mueller P.R. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. Am J Roentgenol 171 (1998) 201-204
8. Slattery J.M., Blake M.A., Kalra M.K., et al. Adrenocortical carcinoma: contrast washout characteristics on CT. AJR Am J Roentgenol 187 (2006) W21-W24
9. Kalra M.K., Blake M.A., Boland G.W., and Hahn P.F. CT features of adrenal pheochromocytomas: attenuation value and loss of contrast enhancement. Radiology 236 (2005) 1112-1113
10. Korobkin M., Giordano T.J., Brodeur F.J., et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200 (1996) 743-747
11. Korobkin M., Lombardi T.J., Aisen A.M., et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 197 (1995) 411-418
12. Outwater E.K., Siegelman E.S., Huang A.B., and Birnbaum B.A. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 200 (1996) 749-752
13. 11C-Metomidate PET imaging of adrenocortical cancer. Eur J Nucl Med Mol Imaging 30 (2003) 403-410
14. 11C]Metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab 91 (2006) 1410-1414
15. Zettinig G., Mitterhauser M., Wadsak W., et al. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging 31 (2004) 1224-1230
16. Minn H., Salonen A., Friberg J., et al. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG. J Nucl Med 45 (2004) 972-979
17. Rana A.I., Kenney P.J., Lockhart M.E., et al. Adrenal gland hematomas in trauma patients. Radiology 230 (2004) 669-675
18. Sinelnikov A.O., Abujudeh H.H., Chan D., and Novelline R.A. CT manifestations of adrenal trauma: experience with 73 cases. Emerg Radiol 13 (2007) 313-318
19. Hoeffel C., Legmann P., Luton J.P., Chapuis Y., and Fayet-Bonnin P. Spontaneous unilateral adrenal hemorrhage: computerized tomography and magnetic resonance imaging findings in 8 cases. J Urol 154 (1995) 1647-1651
20. Ishigami K., Stolpen A.H., Sato Y., Dahmoush L., Winfield H.N., and Fajardo L.L. Adrenal adenoma with organizing hematoma: diagnostic dilemma at MRI. Magn Reson Imaging 22 (2004) 1157-1159
21. Han S.J., Kim T.S., Jeon S.W., et al. Analysis of adrenal masses by 18F-FDG positron emission tomography scanning. Int J Clin Pract 61 (2007) 802-809
22. Jana S., Zhang T., Milstein D.M., Isasi C.R., and Blaufox M.D. FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging 33 (2006) 29-35
23. Metser U., Miller E., Lerman H., Lievshitz G., Avital S., and Even-Sapir E. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 47 (2006) 32-37
24. Caoili E.M., Korobkin M., Brown R.K., Mackie G., and Shulkin B.L. Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation. Acad Radiol 14 (2007) 468-475